Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-139087
Filing Date
2024-12-20
Accepted
2024-12-20 16:30:48
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 apvo-2024-s3_-_20241220.htm S-3 591346
2 EX-5.1 apvo-ex5_1.htm EX-5.1 25816
3 EX-23.1 apvo-ex23_1.htm EX-23.1 4050
4 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 20922
5 GRAPHIC img57496738_0.jpg GRAPHIC 18656
6 GRAPHIC img86535464_0.jpg GRAPHIC 4507
7 GRAPHIC img86535464_1.jpg GRAPHIC 64474
8 GRAPHIC img86535464_2.jpg GRAPHIC 528046
9 GRAPHIC img86535464_3.jpg GRAPHIC 4507
  Complete submission text file 0000950170-24-139087.txt   1497654
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283983 | Film No.: 241568403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)